22-158-013

Murine anti-PON1, Clone: KRJ2, ZeptoMetrix

Manufacturer: Fischer Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 22-158-013-Each-of-1 In Stock ₹ 36,579.00

22-158-013 - Each of 1

₹ 36,579.00

In Stock

Quantity

1

Base Price: ₹ 36,579.00

GST (18%): ₹ 6,584.22

Total Price: ₹ 43,163.22

Antigen

PON1

Classification

Monoclonal

Conjugate

Unconjugated

Host Species

Mouse

Purification Method

Affinity Purified

Regulatory Status

RUO

Target Species

Human

Isotype

IgG1

Applications

Western Blot

Clone

KRJ2

Formulation

100μg in PBS. No preservatives added.

Immunogen

Recombinant human PON1 produced in E. coli

Quantity

100 μg

Primary or Secondary

Primary

Content And Storage

Store at −10°C or below. Avoid freeze/thaw cycles. Thawed material may be stored at 4°C for short-term use.

Related Products

Img

Fischer Scientific

22-158-015

--

Img

Fischer Scientific

22-158-012

--

Img

Fischer Scientific

22-158-014

--

Img

Fischer Scientific

200088787

Mouse Monoclonal Antibody...

Img

Fischer Scientific

3850342

Mouse Monoclonal Antibody...

Img

Fischer Scientific

200089113

Rabbit Polyclonal Antibody...

Img

Fischer Scientific

200088606

Mouse Cocktail Antibody...

Img

Fischer Scientific

200089115

Rabbit Polyclonal Antibody...

Description

  • PON1 (arylesterase/paraoxonase) is a polymorphic enzyme closely associated with high-density lipoproteins (HDL)
  • It is located on chromosome 7 along with 2 other paraoxanase genes, PON2 and PON3
  • It is a 355 amino acid, 43kDa glycoprotein produced in the liver and secreted into the bloodstream
  • Gene polymorphisms occur in both coding and non-coding regions
  • Two major polymorphisms in the coding region are L55M and Q192R
  • Q192R polymorphisms result in three major functional phenotypes Q/Q, Q/R and RR
  • PON1 hydrolyses organophosphates and prevents the oxidation of low-density lipoproteins (LDL)
  • It may inhibit the progression of atherosclerosis by inhibition of LDL oxidation
  • Levels of PON1 in serum vary among individuals and are decreased in chronic renal failure, liver cirrhosis, diabetes, peripheral neuropathy, and familial hypercholesterolemia.